Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 4/20 | 0.41 |
| ▸ | MAOB | P27338 | 4/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11705308 | 0.83 | MAOA (0.40) | MAOAMAOBHTTSLC6A4SLC6A3 | |
| SCHEMBL2042739 | 0.82 | MAOA (0.42) | MAOAMAOBTDP1 | |
| SCHEMBL1499224 | 0.79 | MAPT (0.52) | MEN1KMT2ATDP1HTT | |
| Benzophenone SCHEMBL3179837 | 0.79 | ALDH1A1 (0.42) | MEN1KMT2ATDP1HTT | |
| SCHEMBL11702308 | 0.77 | L3MBTL1 (0.44) | MAOAMAOBMEN1KMT2ASLC6A4 | |
| SCHEMBL7990104 | 0.76 | MAOA (0.56) | MAOAMAOBMEN1KMT2ATDP1 | |
| SCHEMBL817735 | 0.76 | MAOA (0.40) | MAOAMAOBKMT2AHTTSLC6A4 | |
| SCHEMBL13371522 | 0.75 | MEN1 (0.46) | MEN1KMT2ASLC6A4SLC6A3 | |
| SCHEMBL7531296 | 0.75 | TDP1 (0.47) | MAOAMAOBMEN1KMT2ATDP1 | |
| SCHEMBL1536703 | 0.74 | MAOA (0.56) | MAOAMAOBHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104203989-B | Polymerization comprises the compositions of farnesene | 阿迈瑞斯公司 | 2016-10-12 | — | — | CN | disclosed |
| CN-104203989-A | Polymerization of compositions comprising a farnesene | AMYRIS INC | 2014-12-10 | — | — | CN | disclosed |
| US-20120029241-A1 | METHOD FOR PRODUCING CARBONYL COMPOUND, CATALYST, AND METHOD FOR PRODUCING CATALYST | THE UNIVERSITY OF TOKYO (JP) | 2012-02-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120029241-A1 | METHOD FOR PRODUCING CARBONYL COMPOUND, CATALYST, AND METHOD FOR PRODUCING CATALYST | PCCA, PPOX, COASY | MAOA 927/4885MAOB 712/4885MEN1 3360/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.